Search results
Top 15 Best-Selling Cancer Drugs
Insider Monkey via Yahoo Finance· 3 months agoIn this article, we will be discussing the top 15 best-selling cancer drugs. If you are not interested in reading about the global cancer treatment...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters via Yahoo News· 3 months agoBioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 9 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
Roche (RHHBY) Blood Cancer Drug Columvi Wins EC Approval
Zacks via Yahoo Finance· 10 months agoRoche RHHBY obtained conditional marketing authorization from the European Commission (EC) for its...
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Zacks via Yahoo Finance· 5 months agoPuma Biotechnology, Inc.PBYI is a biotechnology company focused on research in cancer. The company’s...
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThe FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Roche's (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal
Zacks via Yahoo Finance· 1 year agoRoche Holding AG’s RHHBY performance in 2022 was pretty average, as the demand for COVID-19 products...
Breast cancer rates are rising. But more women are surviving too
KREX articles via Yahoo News· 7 months agoRapid drug development, personalized screening recommendations, targeted therapies and new...
